The only CEF I own is PDI . We've all heard that Ivascyn has and uses tools that should help protect PDI in a rising rate environment. Based on this, would you intend to hold PDI through a rising rate environment? Thanks in advance for your replies.
I think it may be bit early but worthwhile trying to identify potential CEF that may issue special year end dividends. My top candidate is PDI .. Please indicate ur potential candidates. TIA rs
open I placed an order for 1,600 share of PDI @ $33. Shortly after the open I checked ..... Fidelity account positions noting that my PDI position was not highlighted and showed ..... amazingly it showed "Buy 1600 shares of PDI ." I placed a call to the trading desk
effective expense ratios become more paramount. E.g. relevant to some recent threads we might pick BOI over PDI . Though PDI might still be picked for other predictive technicals such as momentum.
recovery I think aubergine wrote it. PDI is good but is it good enough to justify ..... BOI's 11.6% discount? Not sure. PDI charges 3% on NAV including interest expense ..... effective price tag falls to 1%, whereas PDI 's is still 3%.
but not exclusively) Ivacyn: TLT -long bond (1.72%). IEF -7-10yr (0.63%) PKO +0.28%. PCI. +0.28%. PDI +0.33% The evidence is only preliminary, but hopefully, fixed income portfolio management has grown into a process that
For periods ending 6/30: PDI : NII = 91c - 6c swaps = 85/3 = 28.3c covers 19.1 dist. PCI: Qtr 55 + 5 = 60/3 = 20c covers 15.63 dist Half 96+12
risk scare drives the price lower. I bought this in December so I have a nice gain. Not my usual style to cut and run but could make sense here. I would probably put the funds into DMO/ PDI /BWG. Anyone else thinking of selling out now?
course, this isn't complete by any means. Comments/criticism welcome. LARGE MID-2013 DROP (fully recovered since): PDI JRI LARGE MID-2013 DROP (partially recovered since): TWO KTF LINE RQI BWG PCI MORT NEV MMU JPI BTZ DRP LDP PCEF NQP PFO
On Today's Tables: Insider trades were rated Significant at : Republic Services (NYSE: RSG ); Pimco Dyn Inc Fd (NYSE: PDI ), and; Opko Health (NYSE: OPK ). Insider trades were rated Nearly Significant at: Oncomed Pharm (NASDAQ: OMED ); Inovio